Showing 111-120 of 5048 results for "".
AK Burden and Progression Risk
https://practicaldermatology.com/topics/skin-cancer-photoprotection/ak-burden-and-progression-risk/20134/Individuals with chronic sun damage are at higher risk of developing AK lesions. It is therefore essential that dermatologists emphasize early sun protection recommendations and address progression risks of AK with their patients. Faced with increasing burden of skin cancers, Joel L. Cohen, MD and AThe Benefits of Financial Forecasting in Uncertain Times
https://practicaldermatology.com/topics/practice-management/the-benefits-of-financial-forecasting-in-uncertain-times/23528/Steps for planning for the future to bring back some sense of control.The Secret Sauce of Business Success During COVID-19
https://practicaldermatology.com/topics/practice-management/the-secret-sauce-of-business-success-during-covid-19/23424/How to run an efficient and successful business for the long run.Gene Biomarker Research and Implications for Care
https://practicaldermatology.com/topics/psoriasis/gene-biomarker-research-and-implications-for-care/23374/A tape strip test can differentiate psoriasis from atopic dermatitis based on genetic analysis. How may the finding affect care?Scientifically Speaking: Botulinum Toxin Formulation and Testing
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-botulinum-toxin-formulation-and-testing/19832/Ever wonder about the differences in formulation and manufacture of botulinum neurotoxins? Curious about the trials that support approval? In this edition of Scientifically Speaking, Joel L. Cohen, MD gets the answers to these questions and more from Conor Gallagher, PhD, Head of Medical Affairs, ReCustomized Care: Offering Patients the Best Treatment for Their Unique Situation
https://practicaldermatology.com/topics/skin-cancer-photoprotection/customized-care-offering-patients-the-best-treatment-for-their-unique-situation/23261/While Mohs surgery boasts the highest cure rates for NMSC, dermatologists should be up to date on all options, including SRT.Neurotoxins on the Horizon: Bonti and Beyond
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/neurotoxins-on-the-horizon-bonti-and-beyond/20321/Allergan's acquisition of Bonti highlights the burgeoning potential of the injectable neurotoxin market.The Shape of the Contouring Market: Expert Tips on Energy-based Body Treatments
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-shape-of-the-contouring-market-expert-tips-on-energy-based-body-treatments/20332/Experienced clinicians weigh in on their approach to identifying, educating, and treating patients for body contouring.High-Dose Ipilimumab Shows Benefits in Advanced Melanoma: Implications for Care
https://practicaldermatology.com/topics/skin-cancer-photoprotection/high-dose-ipilimumab-shows-benefits-in-advanced-melanoma-implications-for-care/20687/Although treatment is associated with a high rate of toxicity, survival benefit is extended at a higher dose.Using Social Media to Boost Exposure for Your Dermatology Blog Post
https://practicaldermatology.com/topics/practice-management/using-social-media-to-boost-exposure-for-your-dermatology-blog-post/20733/Here are some creative ideas to widen the reach of your blog post on various social media networks.